API
Faranshimi has been engaged in active pharmaceutical ingredient (API) manufacturing for over 17 years and, combined with our development and supply services, we have the facilities and expertise to take an API from pre-clinical through to commercial scale manufacture.
All of our APIs both generic and proprietary are manufactured according to GMP and appropriate regulatory frameworks. Our focus on operational excellence and continuous improvement ensure our processes are efficient and effective.
We believe in a culture of continuous improvement
As a market leader, we focus on pushing the capabilities of our industry forward, while sharing the benefits with all of our stakeholders and partners. • highly-skilled staff• reduction of manufacturing process cycle times, delivering an increased output
• increase in production yields
• reduction in the cost of manufacture
• standardized turnaround times
Our capabilities include a wide range of reactors and isolation and drying technologies to enable api production on a scale from grams to multi-kilo, supported by comprehensive analytical services and expertise in all the chemistries you expect, as well as many innovative technologies. our objective is to be a reliable partner for supply of high-quality api via a seamless, scalable process that will rapidly achieve your goals at each stage of development, process validation and commercial supply to ensure your future success.
Our key capabilities as active pharmaceutical ingredient suppliers manufacturing
• Our GMP manufacturing plant at Tuyserkan dedicated to API commercial-scale production• License for controlled drug production and facilities for the manufacture and handling of highly potent drug classes active pharmatutical ingredient (API) development
We supply the following generic products worldwide
High-quality APIs and intermediates are made in the same facilities, and to the same stringent standards, as our custom manufacturing projects. These are common building blocks for pharmaceuticals made with an uncommon level of precision.Companies that understand the difference between price and value know that pharmaceuticals will only be as good as their chemical components. Rather than exposing your project to the risks of commoditized materials, sourced from a reputable and trusted partner. Whether you need a kilo for an in-house project or metric tons for a commercial project, with us, you can rely upon this portfolio of APIs and intermediates to make your products their best, and simplify your supply chain.
15 years of generic API manufacturing experience
FaranShimi provides an extensive range of APIs. Our products cover a wide range of therapeutics classes, such as: Analgesic, Narcotics, Antitussive, Opioid Antagonist and Endothelin Receptor Antagonist.| Drug classification | Description | CAS No. | Formula | Standard |
| Narcotic | Buprenorphine Base | 52485-79-7 | C29H41NO4 | BP |
| Narcotic | Buprenorphine HCl | 53152-21-9 | C29H41NO4.HCL | BP |
| Narcotic | Codeine Phosphate | 52-28-8 | C18H21NO3.H3PO4.1/2H2O | BP/USP |
| Narcotic | Codeine Sulfate | 1420-53-7 | C18H23NO7S | USP |
| Narcotic | Methadone Base | 76-99-3 | C21H27NO | In House |
| Narcotic | Methadone HCl | 1095-90-5 | C21H27NO.HCL | BP |
| Narcotic | Morphine HCl | 52-26-6 | C17H20 ClNO3 | BP |
| Narcotic | Morphine Sulfate | 64-31-3 | C34H40N2O10 S | BP |
| Narcotic | Morphine Tartrate | 302-31-8 | C38H44N2O12 | In House |
| Narcotic | Opium Tincture | 57-27-2 | (Morphine) C17H19NO3 | BP/USP |
| Narcotic | Oxycodone Base | 76-42-6 | C18H21NO4 | In house |
| Narcotic | Oxycodone HCl | 124-90-3 | C18H22ClNO4 | BP |
| Drug classification | Description | CAS No. | Formula | Standard |
| Non- narcotic | Bosentan Monohydrate | 157212-55-0 | C27H31N5O7 S | USP |
| Non- narcotic | Naloxone HCl | 357-08-4 | C19H22No4Cl | BP |
| Non- narcotic | Noscapine Base | 128-62-1 | C22H23NO7 | BP/USP |
| Non- narcotic | Noscapine HCl | 912-60-7 | C22H24NO7 Cl | USP |
| Non- narcotic | Papaverine Base | 58-74-2 | C20H21NO4 | In House |
| Non- narcotic | Papaverine HCl | 61-25-6 | C20H22 ClNO4 | BP |
| Non- narcotic Antidiabetic Agents | Sitagliptin Phosphate Monohydrate | 654671-77-9 | C16H20F6N5O6P | BP |
| Non- narcotic Antidiabetic Agents | Empagliflozin | 864070-44-0 | C23H27CIO7 | BP |
| Non- narcotic Antidiabetic Agents | Linagliptin | 668270-12-0 | C25H28N8O2 | In House |
| Non- narcotic Cardiovascular | Apixaban | 503612-47-3 | C25H25N5O4 | In House |
| Non- narcotic Gastrointestinal | Pantoprazole Sodium | 138786-67-1 | C16H14F2N3NaO4S | BP |
